Global Neuroimaging Software Supply, Demand and Key Producers, 2026-2032
The global Neuroimaging Software market size is expected to reach $ 2679 million by 2032, rising at a market growth of 10.0% CAGR during the forecast period (2026-2032).
Neuroimaging Software refers to specialized medical software used to process, quantify, visualize, interpret, and manage analytical outputs derived from imaging of the brain and central nervous system. The market primarily covers software applied to MRI and its advanced sequences, CT/CTA/CTP, PET, SPECT, and multimodal neuroimaging datasets. Core capabilities include image registration and correction, automated tissue and lesion segmentation, brain volumetry and morphometry, perfusion analysis, diffusion and tractography processing, functional brain mapping, molecular imaging quantification, longitudinal change assessment, AI-assisted abnormality detection, and structured reporting. Commercial products are delivered through on-premise workstations, server-based applications, cloud or SaaS platforms, identifiable advanced post-processing modules integrated into imaging environments, and specialized analytical platforms supporting clinical trials and neuroscience research. Neuroimaging Software is primarily used in stroke and cerebrovascular disease, Alzheimer’s disease and other neurodegenerative disorders, multiple sclerosis, neuro-oncology, epilepsy, neurosurgical planning, functional brain assessment, and CNS drug development. The market is characterized by a combination of regulated clinical software, specialized quantitative imaging tools, AI-enabled decision-support applications, and research-oriented commercial platforms.
Value is created when raw imaging data are converted into quantitative measurements, biomarkers, workflow prioritization, treatment-planning information or longitudinal evidence that improves decision consistency and reduces manual analytical work. Downstream users include hospitals, imaging centers, neurology and neurosurgery departments, pharmaceutical and biotechnology companies, CROs and research institutions. Cost structures are dominated by software R&D, clinical validation, regulatory compliance, data acquisition and curation, cloud infrastructure, cybersecurity, integration, sales and implementation. As deployment moves toward recurring SaaS and enterprise models, scalable software economics become more important, but clinical support, integration and regulatory maintenance remain meaningful cost components.
The fastest-evolving opportunity set is concentrated around quantitative and treatment-linked applications rather than basic image viewing. Automated brain segmentation, hippocampal and regional volumetry, cortical and lesion measurement, ARIA assessment and longitudinal change analysis are becoming increasingly differentiated commercial functions. CMS documentation recognizes multiple FDA-cleared products addressing automated labeling, visualization and volumetric quantification of brain MRI, as well as dedicated ARIA analysis, supporting the emergence of a more defined regulated quantitative-neuroimaging segment. Functional MRI, DTI, tractography, connectomics and molecular neuroimaging remain smaller but technically differentiated segments with strong relevance in neurosurgery, research and CNS drug development.
Asia-Pacific is becoming more strategically important but remains structurally fragmented. Japan combines global imaging OEMs with domestic neurological AI developers, while South Korea has developed a relatively dense cluster of specialist brain-imaging AI companies focused on volumetry, stroke, Parkinson’s disease, intracranial hemorrhage and cerebrovascular analysis. China has a growing medical-AI ecosystem, although the stricter product-evidence standard applied in this study results in a smaller Core Formal List than in Europe or North America. Taiwan and Australia contribute several niche vendors in diffusion MRI, brain metastasis analysis, perfusion and quantitative neuroimaging. The regional opportunity therefore lies less in simple geographic expansion and more in localization, regulatory approval, hospital integration and adaptation to country-specific clinical workflows.
This report is a detailed and comprehensive analysis of the world market for Neuroimaging Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuroimaging Software that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neuroimaging Software market
2. What is the demand of the global Neuroimaging Software market?
3. What is the year over year growth of the global Neuroimaging Software market?
4. What is the total value of the global Neuroimaging Software market?
5. Who are the Major Players in the global Neuroimaging Software market?
6. What are the growth factors driving the market demand?
Neuroimaging Software refers to specialized medical software used to process, quantify, visualize, interpret, and manage analytical outputs derived from imaging of the brain and central nervous system. The market primarily covers software applied to MRI and its advanced sequences, CT/CTA/CTP, PET, SPECT, and multimodal neuroimaging datasets. Core capabilities include image registration and correction, automated tissue and lesion segmentation, brain volumetry and morphometry, perfusion analysis, diffusion and tractography processing, functional brain mapping, molecular imaging quantification, longitudinal change assessment, AI-assisted abnormality detection, and structured reporting. Commercial products are delivered through on-premise workstations, server-based applications, cloud or SaaS platforms, identifiable advanced post-processing modules integrated into imaging environments, and specialized analytical platforms supporting clinical trials and neuroscience research. Neuroimaging Software is primarily used in stroke and cerebrovascular disease, Alzheimer’s disease and other neurodegenerative disorders, multiple sclerosis, neuro-oncology, epilepsy, neurosurgical planning, functional brain assessment, and CNS drug development. The market is characterized by a combination of regulated clinical software, specialized quantitative imaging tools, AI-enabled decision-support applications, and research-oriented commercial platforms.
Key Findings
- Europe has the densest specialist supplier base, while North America combines major imaging platforms with leading neurovascular and surgical-planning vendors
- Stroke and cerebrovascular imaging remain commercially established applications, while neurodegenerative monitoring is becoming a more important source of incremental demand
- MRI-based quantification is expanding from diagnostic assessment toward treatment eligibility, longitudinal monitoring and ARIA evaluation
Market Trends
Neuroimaging Software is shifting from isolated post-processing tools and single-purpose algorithms toward integrated, multimodal and longitudinal analytical workflows. MRI remains central to quantitative brain analysis, while CT-based stroke applications, PET and SPECT quantification, diffusion imaging, functional MRI and multimodal fusion broaden the addressable clinical workflows. Product development is increasingly focused on automated segmentation, quantitative biomarkers, longitudinal comparison, structured reporting and cloud-enabled delivery rather than stand-alone visualization alone. The expansion of disease-modifying therapies for Alzheimer’s disease is also strengthening the role of quantitative MRI and treatment-safety monitoring. In August 2025, the U.S. FDA required an additional earlier MRI monitoring point for patients receiving lecanemab because of ARIA risk, reinforcing the importance of repeatable brain-image assessment during therapy. At the same time, consolidation is accelerating as larger imaging and digital-health groups acquire specialized analytical technologies: GE HealthCare completed its acquisition of icometrix in 2025, SyntheticMR completed its acquisition of Combinostics, and RadNet acquired Gleamer for integration into DeepHealth in March 2026.Market Dynamics
Drivers
Demand for Neuroimaging Software is being supported by the rising clinical need for faster and more standardized interpretation of complex neurological imaging, together with increasing use of quantitative biomarkers in stroke, dementia, multiple sclerosis, neuro-oncology and neurosurgical planning. Hospital systems are seeking tools that reduce manual measurement, improve consistency across readers and accelerate time-sensitive workflows, particularly in acute stroke. Another important driver is the growing role of imaging in treatment selection and safety monitoring for neurodegenerative therapies. FDA requirements for additional MRI monitoring during lecanemab therapy illustrate how imaging is becoming more closely connected to longitudinal therapeutic management rather than one-time diagnosis alone. CNS drug development also creates demand for standardized MRI and PET analysis across sites and time points, supporting specialized clinical-trial imaging and biomarker platforms.Restraints
Market adoption remains constrained by fragmented reimbursement, lengthy hospital procurement cycles, regulatory requirements, interoperability issues and the cost of integrating analytical software into existing radiology and clinical workflows. Neuroimaging algorithms must also perform consistently across scanners, protocols, patient populations and imaging quality levels, increasing the cost of validation and product maintenance. In research-oriented applications, widely used academic and open-source software continues to limit pricing power for commercial vendors. Large imaging OEMs can also bundle advanced post-processing functions into broader workstation or enterprise-imaging contracts, which can reduce the addressable stand-alone software value for independent suppliers. These factors mean that technically strong products do not automatically translate into rapid commercial adoption, particularly where the clinical workflow benefit or reimbursement pathway is not clearly defined.Opportunities
The most attractive opportunities are emerging where Neuroimaging Software moves beyond image visualization to support treatment pathways, measurable biomarkers and longitudinal disease management. Quantitative MRI for Alzheimer’s disease, ARIA assessment, automated brain volumetry, multiple-sclerosis monitoring, PET-based neurodegenerative biomarkers and treatment-response analysis are becoming increasingly relevant. CMS documentation on automated brain MRI detection and quantification identifies regulated commercial products for brain volumetry, ARIA analysis and morphometric assessment, demonstrating that these applications are moving toward identifiable clinical software categories. Additional opportunities exist in vendor-neutral cloud deployment, multimodal MRI/PET analysis, CNS clinical trials, smaller hospitals that lack specialist neuroradiology resources, and emerging Asian markets where domestic medical-AI suppliers are building localized neuroimaging products.Challenges
The principal long-term challenge is converting algorithmic performance into repeatable clinical and economic value. Regulatory clearance alone does not guarantee reimbursement, workflow adoption or sustained usage, and suppliers must continuously demonstrate reliability across diverse populations and imaging environments. Competitive intensity is also rising as specialized algorithms become integrated into larger enterprise-imaging, AI-orchestration and scanner-vendor ecosystems. Consolidation may increase access to distribution while simultaneously reducing the number of independent purchasing decisions available to smaller vendors. Data privacy requirements, cross-border cloud deployment rules, cybersecurity expectations and evolving AI regulation add further complexity. The market therefore favors companies that can combine validated algorithms with clinical integration, scalable deployment, regulatory execution and durable relationships with hospitals or pharmaceutical customers.Value Chain Analysis
The Neuroimaging Software value chain begins with medical imaging data, computational infrastructure, image-processing frameworks, anatomical atlases, clinically annotated datasets and algorithm-development capabilities. These inputs support the development of segmentation, registration, volumetric analysis, perfusion modeling, diffusion analysis, functional mapping, molecular imaging quantification and AI-based detection tools. The midstream layer consists of specialized software companies, medical-imaging OEMs, clinical AI developers, nuclear-medicine software providers, neurosurgical planning vendors and CNS imaging platforms. Products are commercialized through perpetual or term licenses, enterprise subscriptions, SaaS contracts, per-scan or usage-based models, OEM embedding arrangements and clinical-trial contracts.Value is created when raw imaging data are converted into quantitative measurements, biomarkers, workflow prioritization, treatment-planning information or longitudinal evidence that improves decision consistency and reduces manual analytical work. Downstream users include hospitals, imaging centers, neurology and neurosurgery departments, pharmaceutical and biotechnology companies, CROs and research institutions. Cost structures are dominated by software R&D, clinical validation, regulatory compliance, data acquisition and curation, cloud infrastructure, cybersecurity, integration, sales and implementation. As deployment moves toward recurring SaaS and enterprise models, scalable software economics become more important, but clinical support, integration and regulatory maintenance remain meaningful cost components.
Segment Insights
From a product-function perspective, the market contains several commercially meaningful segments rather than a single homogeneous software category. Acute stroke and neurovascular analysis is one of the most established clinical applications because software outputs can be integrated directly into time-sensitive emergency workflows. Advanced post-processing and visualization also represent an established installed-base segment through major imaging vendors. Quantitative brain MRI, neurodegenerative disease assessment and longitudinal biomarker analysis are gaining strategic importance as neurological treatment pathways increasingly require repeatable measurements rather than qualitative interpretation alone. MRI-related applications represent the broadest product coverage across the identified supplier universe, spanning structural volumetry, diffusion imaging, functional mapping, perfusion, multiple-sclerosis analysis and neuro-oncology.The fastest-evolving opportunity set is concentrated around quantitative and treatment-linked applications rather than basic image viewing. Automated brain segmentation, hippocampal and regional volumetry, cortical and lesion measurement, ARIA assessment and longitudinal change analysis are becoming increasingly differentiated commercial functions. CMS documentation recognizes multiple FDA-cleared products addressing automated labeling, visualization and volumetric quantification of brain MRI, as well as dedicated ARIA analysis, supporting the emergence of a more defined regulated quantitative-neuroimaging segment. Functional MRI, DTI, tractography, connectomics and molecular neuroimaging remain smaller but technically differentiated segments with strong relevance in neurosurgery, research and CNS drug development.
Downstream Market Opportunities
Hospitals and diagnostic imaging centers remain the primary commercial users of Neuroimaging Software, but the demand profile is widening beyond the radiology department. Stroke centers require rapid neurovascular triage and perfusion analysis, neurology services increasingly use quantitative MRI for neurodegenerative and demyelinating diseases, and neurosurgical teams require multimodal fusion, tractography and functional mapping for preoperative planning. Pharmaceutical and biotechnology companies represent an increasingly strategic downstream opportunity because CNS drug programs depend on standardized longitudinal imaging biomarkers, patient stratification and safety monitoring. This creates room for software suppliers that can bridge routine clinical imaging and research-grade quantitative analysis. Smaller hospitals and imaging networks also represent an underpenetrated opportunity as cloud-based deployment reduces the need for dedicated local workstations and specialist post-processing resources.Regional Insights
Europe has the largest concentration of identified independent specialist Neuroimaging Software suppliers, particularly in quantitative brain MRI, perfusion, nuclear medicine, functional imaging and neurodegenerative disease analysis. The region combines established medical-imaging technology clusters with a relatively broad base of smaller specialist developers. North America has a different competitive structure: major imaging and digital-health platforms coexist with commercially advanced stroke-AI, neurosurgical planning, quantitative imaging and research-software providers. The region remains particularly important for regulated clinical commercialization because FDA clearance, large hospital networks and pharmaceutical demand can support broader deployment of successful products. CMS activity around automated brain MRI quantification also highlights increasing attention to the clinical and reimbursement framework for quantitative neuroimaging.Asia-Pacific is becoming more strategically important but remains structurally fragmented. Japan combines global imaging OEMs with domestic neurological AI developers, while South Korea has developed a relatively dense cluster of specialist brain-imaging AI companies focused on volumetry, stroke, Parkinson’s disease, intracranial hemorrhage and cerebrovascular analysis. China has a growing medical-AI ecosystem, although the stricter product-evidence standard applied in this study results in a smaller Core Formal List than in Europe or North America. Taiwan and Australia contribute several niche vendors in diffusion MRI, brain metastasis analysis, perfusion and quantitative neuroimaging. The regional opportunity therefore lies less in simple geographic expansion and more in localization, regulatory approval, hospital integration and adaptation to country-specific clinical workflows.
Competitive Landscape Analysis
The Neuroimaging Software market has a layered competitive structure rather than a single group of directly comparable competitors. Major imaging OEMs compete through scanner installed bases, integrated workstations, enterprise-imaging relationships and global distribution, while independent specialists compete through deeper algorithms and clinical focus in stroke, brain volumetry, neurodegeneration, perfusion, molecular imaging, fMRI/DTI, neuro-oncology and neurosurgical planning. The study identifies 61 companies in the Core Formal List, demonstrating that the commercially relevant supplier base extends well beyond a small group of global imaging companies. Competitive consolidation is increasing as larger platforms acquire specialized software capabilities. GE HealthCare closed its acquisition of icometrix in 2025 to strengthen neurological MRI analysis, SyntheticMR acquired Combinostics to broaden quantitative neuroimaging capabilities, and RadNet acquired Gleamer in 2026 to expand DeepHealth’s clinical AI portfolio. These transactions point toward continued integration of specialist algorithms into broader imaging ecosystems, but highly differentiated areas such as ARIA quantification, connectomics, advanced perfusion, molecular imaging and functional brain mapping continue to provide defensible positions for focused vendors.Report Scope
This report studies the global Neuroimaging Software demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Neuroimaging Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuroimaging Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Neuroimaging Software total market, 2021-2032, (USD Million)
- Global Neuroimaging Software total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Neuroimaging Software total market, key domestic companies, and share, (USD Million)
- Global Neuroimaging Software revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Neuroimaging Software total market by Type, CAGR, 2021-2032, (USD Million)
- Global Neuroimaging Software total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neuroimaging Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Neuroimaging Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Neuroimaging Software Market, Segmentation by Type:
- Advanced Post-processing and Visualization
- Quantitative Biomarkers and Volumetry
- AI Detection
- Molecular Neuroimaging Quantification
- Others
Global Neuroimaging Software Market, Segmentation by Deployment Model:
- On-premise
- Cloud-based
- Hybrid
Global Neuroimaging Software Market, Segmentation by Intended Use:
- Clinical Diagnostic or Decision Support
- Clinical Trial or Drug Development
- Research Use Only
- Others
Global Neuroimaging Software Market, Segmentation by Application:
- Stroke and Cerebrovascular Disease
- Neurodegenerative Disease and Multiple Sclerosis
- Neuro-oncology
- Others
Companies Profiled:
- GE HealthCare
- Siemens Healthineers
- RapidAI
- Viz.ai
- Philips
- Brainlab
- Canon
- Fujifilm
- Brainomix
- Bruker
- Cortechs.ai
- RadNet
- Aidoc
- ConcertAI
- Qure.ai
- United Imaging Intelligence
- Shukun Technology
- Infervision
- Stryker
- Nicolab
- Avicenna.AI
- Synaptive Medical
- Quibim
- Surgical Theater
- mediaire
- Qynapse
- Thermo Fisher
- Hermes Medical Solutions
- Omniscient Neurotechnology
- IQ-AI
- Neurophet
- LPIXEL
- JLK
- Brainreader
- NordicNeuroLab
- VUNO
- Heuron
- Coreline Soft
- Cercare Medical
Key Questions Answered
1. How big is the global Neuroimaging Software market?2. What is the demand of the global Neuroimaging Software market?
3. What is the year over year growth of the global Neuroimaging Software market?
4. What is the total value of the global Neuroimaging Software market?
5. Who are the Major Players in the global Neuroimaging Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neuroimaging Software Introduction
1.2 World Neuroimaging Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neuroimaging Software Total Market by Region (by Headquarter Location)
1.3.1 World Neuroimaging Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neuroimaging Software Revenue (2021-2032)
1.3.3 China Based Company Neuroimaging Software Revenue (2021-2032)
1.3.4 Europe Based Company Neuroimaging Software Revenue (2021-2032)
1.3.5 Japan Based Company Neuroimaging Software Revenue (2021-2032)
1.3.6 South Korea Based Company Neuroimaging Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Neuroimaging Software Revenue (2021-2032)
1.3.8 India Based Company Neuroimaging Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuroimaging Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuroimaging Software Consumption Value (2021-2032)
2.2 World Neuroimaging Software Consumption Value by Region
2.2.1 World Neuroimaging Software Consumption Value by Region (2021-2026)
2.2.2 World Neuroimaging Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Neuroimaging Software Consumption Value (2021-2032)
2.4 China Neuroimaging Software Consumption Value (2021-2032)
2.5 Europe Neuroimaging Software Consumption Value (2021-2032)
2.6 Japan Neuroimaging Software Consumption Value (2021-2032)
2.7 South Korea Neuroimaging Software Consumption Value (2021-2032)
2.8 ASEAN Neuroimaging Software Consumption Value (2021-2032)
2.9 India Neuroimaging Software Consumption Value (2021-2032)
3 WORLD NEUROIMAGING SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Neuroimaging Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuroimaging Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuroimaging Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Neuroimaging Software in 2025
3.3 Neuroimaging Software Company Evaluation Quadrant
3.4 Neuroimaging Software Market: Overall Company Footprint Analysis
3.4.1 Neuroimaging Software Market: Region Footprint
3.4.2 Neuroimaging Software Market: Company Product Type Footprint
3.4.3 Neuroimaging Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neuroimaging Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuroimaging Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neuroimaging Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neuroimaging Software Consumption Value Comparison
4.2.1 United States VS China: Neuroimaging Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neuroimaging Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neuroimaging Software Companies and Market Share, 2021-2026
4.3.1 United States Based Neuroimaging Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuroimaging Software Revenue, (2021-2026)
4.4 China Based Companies Neuroimaging Software Revenue and Market Share, 2021-2026
4.4.1 China Based Neuroimaging Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuroimaging Software Revenue, (2021-2026)
4.5 Rest of World Based Neuroimaging Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neuroimaging Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neuroimaging Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuroimaging Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Advanced Post-processing and Visualization
5.2.2 Quantitative Biomarkers and Volumetry
5.2.3 AI Detection
5.2.4 Molecular Neuroimaging Quantification
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neuroimaging Software Market Size by Type (2021-2026)
5.3.2 World Neuroimaging Software Market Size by Type (2027-2032)
5.3.3 World Neuroimaging Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODEL
6.1 World Neuroimaging Software Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Model
6.2.1 On-premise
6.2.2 Cloud-based
6.2.3 Hybrid
6.3 Market Segment by Deployment Model
6.3.1 World Neuroimaging Software Market Size by Deployment Model (2021-2026)
6.3.2 World Neuroimaging Software Market Size by Deployment Model (2027-2032)
6.3.3 World Neuroimaging Software Market Size Market Share by Deployment Model (2027-2032)
7 MARKET ANALYSIS BY INTENDED USE
7.1 World Neuroimaging Software Market Size Overview by Intended Use: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Intended Use
7.2.1 Clinical Diagnostic or Decision Support
7.2.2 Clinical Trial or Drug Development
7.2.3 Research Use Only
7.2.4 Others
7.3 Market Segment by Intended Use
7.3.1 World Neuroimaging Software Market Size by Intended Use (2021-2026)
7.3.2 World Neuroimaging Software Market Size by Intended Use (2027-2032)
7.3.3 World Neuroimaging Software Market Size Market Share by Intended Use (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neuroimaging Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Stroke and Cerebrovascular Disease
8.2.2 Neurodegenerative Disease and Multiple Sclerosis
8.2.3 Neuro-oncology
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Neuroimaging Software Market Size by Application (2021-2026)
8.3.2 World Neuroimaging Software Market Size by Application (2027-2032)
8.3.3 World Neuroimaging Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GE HealthCare
9.1.1 GE HealthCare Details
9.1.2 GE HealthCare Major Business
9.1.3 GE HealthCare Neuroimaging Software Product and Services
9.1.4 GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GE HealthCare Recent Developments/Updates
9.1.6 GE HealthCare Competitive Strengths & Weaknesses
9.2 Siemens Healthineers
9.2.1 Siemens Healthineers Details
9.2.2 Siemens Healthineers Major Business
9.2.3 Siemens Healthineers Neuroimaging Software Product and Services
9.2.4 Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Siemens Healthineers Recent Developments/Updates
9.2.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.3 RapidAI
9.3.1 RapidAI Details
9.3.2 RapidAI Major Business
9.3.3 RapidAI Neuroimaging Software Product and Services
9.3.4 RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 RapidAI Recent Developments/Updates
9.3.6 RapidAI Competitive Strengths & Weaknesses
9.4 Viz.ai
9.4.1 Viz.ai Details
9.4.2 Viz.ai Major Business
9.4.3 Viz.ai Neuroimaging Software Product and Services
9.4.4 Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Viz.ai Recent Developments/Updates
9.4.6 Viz.ai Competitive Strengths & Weaknesses
9.5 Philips
9.5.1 Philips Details
9.5.2 Philips Major Business
9.5.3 Philips Neuroimaging Software Product and Services
9.5.4 Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Philips Recent Developments/Updates
9.5.6 Philips Competitive Strengths & Weaknesses
9.6 Brainlab
9.6.1 Brainlab Details
9.6.2 Brainlab Major Business
9.6.3 Brainlab Neuroimaging Software Product and Services
9.6.4 Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Brainlab Recent Developments/Updates
9.6.6 Brainlab Competitive Strengths & Weaknesses
9.7 Canon
9.7.1 Canon Details
9.7.2 Canon Major Business
9.7.3 Canon Neuroimaging Software Product and Services
9.7.4 Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Canon Recent Developments/Updates
9.7.6 Canon Competitive Strengths & Weaknesses
9.8 Fujifilm
9.8.1 Fujifilm Details
9.8.2 Fujifilm Major Business
9.8.3 Fujifilm Neuroimaging Software Product and Services
9.8.4 Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Fujifilm Recent Developments/Updates
9.8.6 Fujifilm Competitive Strengths & Weaknesses
9.9 Brainomix
9.9.1 Brainomix Details
9.9.2 Brainomix Major Business
9.9.3 Brainomix Neuroimaging Software Product and Services
9.9.4 Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Brainomix Recent Developments/Updates
9.9.6 Brainomix Competitive Strengths & Weaknesses
9.10 Bruker
9.10.1 Bruker Details
9.10.2 Bruker Major Business
9.10.3 Bruker Neuroimaging Software Product and Services
9.10.4 Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Bruker Recent Developments/Updates
9.10.6 Bruker Competitive Strengths & Weaknesses
9.11 Cortechs.ai
9.11.1 Cortechs.ai Details
9.11.2 Cortechs.ai Major Business
9.11.3 Cortechs.ai Neuroimaging Software Product and Services
9.11.4 Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cortechs.ai Recent Developments/Updates
9.11.6 Cortechs.ai Competitive Strengths & Weaknesses
9.12 RadNet
9.12.1 RadNet Details
9.12.2 RadNet Major Business
9.12.3 RadNet Neuroimaging Software Product and Services
9.12.4 RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 RadNet Recent Developments/Updates
9.12.6 RadNet Competitive Strengths & Weaknesses
9.13 Aidoc
9.13.1 Aidoc Details
9.13.2 Aidoc Major Business
9.13.3 Aidoc Neuroimaging Software Product and Services
9.13.4 Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Aidoc Recent Developments/Updates
9.13.6 Aidoc Competitive Strengths & Weaknesses
9.14 ConcertAI
9.14.1 ConcertAI Details
9.14.2 ConcertAI Major Business
9.14.3 ConcertAI Neuroimaging Software Product and Services
9.14.4 ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 ConcertAI Recent Developments/Updates
9.14.6 ConcertAI Competitive Strengths & Weaknesses
9.15 Qure.ai
9.15.1 Qure.ai Details
9.15.2 Qure.ai Major Business
9.15.3 Qure.ai Neuroimaging Software Product and Services
9.15.4 Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Qure.ai Recent Developments/Updates
9.15.6 Qure.ai Competitive Strengths & Weaknesses
9.16 United Imaging Intelligence
9.16.1 United Imaging Intelligence Details
9.16.2 United Imaging Intelligence Major Business
9.16.3 United Imaging Intelligence Neuroimaging Software Product and Services
9.16.4 United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 United Imaging Intelligence Recent Developments/Updates
9.16.6 United Imaging Intelligence Competitive Strengths & Weaknesses
9.17 Shukun Technology
9.17.1 Shukun Technology Details
9.17.2 Shukun Technology Major Business
9.17.3 Shukun Technology Neuroimaging Software Product and Services
9.17.4 Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shukun Technology Recent Developments/Updates
9.17.6 Shukun Technology Competitive Strengths & Weaknesses
9.18 Infervision
9.18.1 Infervision Details
9.18.2 Infervision Major Business
9.18.3 Infervision Neuroimaging Software Product and Services
9.18.4 Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Infervision Recent Developments/Updates
9.18.6 Infervision Competitive Strengths & Weaknesses
9.19 Stryker
9.19.1 Stryker Details
9.19.2 Stryker Major Business
9.19.3 Stryker Neuroimaging Software Product and Services
9.19.4 Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Stryker Recent Developments/Updates
9.19.6 Stryker Competitive Strengths & Weaknesses
9.20 Nicolab
9.20.1 Nicolab Details
9.20.2 Nicolab Major Business
9.20.3 Nicolab Neuroimaging Software Product and Services
9.20.4 Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Nicolab Recent Developments/Updates
9.20.6 Nicolab Competitive Strengths & Weaknesses
9.21 Avicenna.AI
9.21.1 Avicenna.AI Details
9.21.2 Avicenna.AI Major Business
9.21.3 Avicenna.AI Neuroimaging Software Product and Services
9.21.4 Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Avicenna.AI Recent Developments/Updates
9.21.6 Avicenna.AI Competitive Strengths & Weaknesses
9.22 Synaptive Medical
9.22.1 Synaptive Medical Details
9.22.2 Synaptive Medical Major Business
9.22.3 Synaptive Medical Neuroimaging Software Product and Services
9.22.4 Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Synaptive Medical Recent Developments/Updates
9.22.6 Synaptive Medical Competitive Strengths & Weaknesses
9.23 Quibim
9.23.1 Quibim Details
9.23.2 Quibim Major Business
9.23.3 Quibim Neuroimaging Software Product and Services
9.23.4 Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Quibim Recent Developments/Updates
9.23.6 Quibim Competitive Strengths & Weaknesses
9.24 Surgical Theater
9.24.1 Surgical Theater Details
9.24.2 Surgical Theater Major Business
9.24.3 Surgical Theater Neuroimaging Software Product and Services
9.24.4 Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Surgical Theater Recent Developments/Updates
9.24.6 Surgical Theater Competitive Strengths & Weaknesses
9.25 mediaire
9.25.1 mediaire Details
9.25.2 mediaire Major Business
9.25.3 mediaire Neuroimaging Software Product and Services
9.25.4 mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 mediaire Recent Developments/Updates
9.25.6 mediaire Competitive Strengths & Weaknesses
9.26 Qynapse
9.26.1 Qynapse Details
9.26.2 Qynapse Major Business
9.26.3 Qynapse Neuroimaging Software Product and Services
9.26.4 Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Qynapse Recent Developments/Updates
9.26.6 Qynapse Competitive Strengths & Weaknesses
9.27 Thermo Fisher
9.27.1 Thermo Fisher Details
9.27.2 Thermo Fisher Major Business
9.27.3 Thermo Fisher Neuroimaging Software Product and Services
9.27.4 Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Thermo Fisher Recent Developments/Updates
9.27.6 Thermo Fisher Competitive Strengths & Weaknesses
9.28 Hermes Medical Solutions
9.28.1 Hermes Medical Solutions Details
9.28.2 Hermes Medical Solutions Major Business
9.28.3 Hermes Medical Solutions Neuroimaging Software Product and Services
9.28.4 Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Hermes Medical Solutions Recent Developments/Updates
9.28.6 Hermes Medical Solutions Competitive Strengths & Weaknesses
9.29 Omniscient Neurotechnology
9.29.1 Omniscient Neurotechnology Details
9.29.2 Omniscient Neurotechnology Major Business
9.29.3 Omniscient Neurotechnology Neuroimaging Software Product and Services
9.29.4 Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Omniscient Neurotechnology Recent Developments/Updates
9.29.6 Omniscient Neurotechnology Competitive Strengths & Weaknesses
9.30 IQ-AI
9.30.1 IQ-AI Details
9.30.2 IQ-AI Major Business
9.30.3 IQ-AI Neuroimaging Software Product and Services
9.30.4 IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 IQ-AI Recent Developments/Updates
9.30.6 IQ-AI Competitive Strengths & Weaknesses
9.31 Neurophet
9.31.1 Neurophet Details
9.31.2 Neurophet Major Business
9.31.3 Neurophet Neuroimaging Software Product and Services
9.31.4 Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Neurophet Recent Developments/Updates
9.31.6 Neurophet Competitive Strengths & Weaknesses
9.32 LPIXEL
9.32.1 LPIXEL Details
9.32.2 LPIXEL Major Business
9.32.3 LPIXEL Neuroimaging Software Product and Services
9.32.4 LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 LPIXEL Recent Developments/Updates
9.32.6 LPIXEL Competitive Strengths & Weaknesses
9.33 JLK
9.33.1 JLK Details
9.33.2 JLK Major Business
9.33.3 JLK Neuroimaging Software Product and Services
9.33.4 JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 JLK Recent Developments/Updates
9.33.6 JLK Competitive Strengths & Weaknesses
9.34 Brainreader
9.34.1 Brainreader Details
9.34.2 Brainreader Major Business
9.34.3 Brainreader Neuroimaging Software Product and Services
9.34.4 Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Brainreader Recent Developments/Updates
9.34.6 Brainreader Competitive Strengths & Weaknesses
9.35 NordicNeuroLab
9.35.1 NordicNeuroLab Details
9.35.2 NordicNeuroLab Major Business
9.35.3 NordicNeuroLab Neuroimaging Software Product and Services
9.35.4 NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 NordicNeuroLab Recent Developments/Updates
9.35.6 NordicNeuroLab Competitive Strengths & Weaknesses
9.36 VUNO
9.36.1 VUNO Details
9.36.2 VUNO Major Business
9.36.3 VUNO Neuroimaging Software Product and Services
9.36.4 VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 VUNO Recent Developments/Updates
9.36.6 VUNO Competitive Strengths & Weaknesses
9.37 Heuron
9.37.1 Heuron Details
9.37.2 Heuron Major Business
9.37.3 Heuron Neuroimaging Software Product and Services
9.37.4 Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 Heuron Recent Developments/Updates
9.37.6 Heuron Competitive Strengths & Weaknesses
9.38 Coreline Soft
9.38.1 Coreline Soft Details
9.38.2 Coreline Soft Major Business
9.38.3 Coreline Soft Neuroimaging Software Product and Services
9.38.4 Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Coreline Soft Recent Developments/Updates
9.38.6 Coreline Soft Competitive Strengths & Weaknesses
9.39 Cercare Medical
9.39.1 Cercare Medical Details
9.39.2 Cercare Medical Major Business
9.39.3 Cercare Medical Neuroimaging Software Product and Services
9.39.4 Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Cercare Medical Recent Developments/Updates
9.39.6 Cercare Medical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neuroimaging Software Industry Chain
10.2 Neuroimaging Software Upstream Analysis
10.3 Neuroimaging Software Midstream Analysis
10.4 Neuroimaging Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Neuroimaging Software Introduction
1.2 World Neuroimaging Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neuroimaging Software Total Market by Region (by Headquarter Location)
1.3.1 World Neuroimaging Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neuroimaging Software Revenue (2021-2032)
1.3.3 China Based Company Neuroimaging Software Revenue (2021-2032)
1.3.4 Europe Based Company Neuroimaging Software Revenue (2021-2032)
1.3.5 Japan Based Company Neuroimaging Software Revenue (2021-2032)
1.3.6 South Korea Based Company Neuroimaging Software Revenue (2021-2032)
1.3.7 ASEAN Based Company Neuroimaging Software Revenue (2021-2032)
1.3.8 India Based Company Neuroimaging Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuroimaging Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuroimaging Software Consumption Value (2021-2032)
2.2 World Neuroimaging Software Consumption Value by Region
2.2.1 World Neuroimaging Software Consumption Value by Region (2021-2026)
2.2.2 World Neuroimaging Software Consumption Value Forecast by Region (2027-2032)
2.3 United States Neuroimaging Software Consumption Value (2021-2032)
2.4 China Neuroimaging Software Consumption Value (2021-2032)
2.5 Europe Neuroimaging Software Consumption Value (2021-2032)
2.6 Japan Neuroimaging Software Consumption Value (2021-2032)
2.7 South Korea Neuroimaging Software Consumption Value (2021-2032)
2.8 ASEAN Neuroimaging Software Consumption Value (2021-2032)
2.9 India Neuroimaging Software Consumption Value (2021-2032)
3 WORLD NEUROIMAGING SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Neuroimaging Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neuroimaging Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neuroimaging Software in 2025
3.2.3 Global Concentration Ratios (CR8) for Neuroimaging Software in 2025
3.3 Neuroimaging Software Company Evaluation Quadrant
3.4 Neuroimaging Software Market: Overall Company Footprint Analysis
3.4.1 Neuroimaging Software Market: Region Footprint
3.4.2 Neuroimaging Software Market: Company Product Type Footprint
3.4.3 Neuroimaging Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neuroimaging Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neuroimaging Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neuroimaging Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neuroimaging Software Consumption Value Comparison
4.2.1 United States VS China: Neuroimaging Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neuroimaging Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neuroimaging Software Companies and Market Share, 2021-2026
4.3.1 United States Based Neuroimaging Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neuroimaging Software Revenue, (2021-2026)
4.4 China Based Companies Neuroimaging Software Revenue and Market Share, 2021-2026
4.4.1 China Based Neuroimaging Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neuroimaging Software Revenue, (2021-2026)
4.5 Rest of World Based Neuroimaging Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neuroimaging Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neuroimaging Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuroimaging Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Advanced Post-processing and Visualization
5.2.2 Quantitative Biomarkers and Volumetry
5.2.3 AI Detection
5.2.4 Molecular Neuroimaging Quantification
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neuroimaging Software Market Size by Type (2021-2026)
5.3.2 World Neuroimaging Software Market Size by Type (2027-2032)
5.3.3 World Neuroimaging Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODEL
6.1 World Neuroimaging Software Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Model
6.2.1 On-premise
6.2.2 Cloud-based
6.2.3 Hybrid
6.3 Market Segment by Deployment Model
6.3.1 World Neuroimaging Software Market Size by Deployment Model (2021-2026)
6.3.2 World Neuroimaging Software Market Size by Deployment Model (2027-2032)
6.3.3 World Neuroimaging Software Market Size Market Share by Deployment Model (2027-2032)
7 MARKET ANALYSIS BY INTENDED USE
7.1 World Neuroimaging Software Market Size Overview by Intended Use: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Intended Use
7.2.1 Clinical Diagnostic or Decision Support
7.2.2 Clinical Trial or Drug Development
7.2.3 Research Use Only
7.2.4 Others
7.3 Market Segment by Intended Use
7.3.1 World Neuroimaging Software Market Size by Intended Use (2021-2026)
7.3.2 World Neuroimaging Software Market Size by Intended Use (2027-2032)
7.3.3 World Neuroimaging Software Market Size Market Share by Intended Use (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neuroimaging Software Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Stroke and Cerebrovascular Disease
8.2.2 Neurodegenerative Disease and Multiple Sclerosis
8.2.3 Neuro-oncology
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Neuroimaging Software Market Size by Application (2021-2026)
8.3.2 World Neuroimaging Software Market Size by Application (2027-2032)
8.3.3 World Neuroimaging Software Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GE HealthCare
9.1.1 GE HealthCare Details
9.1.2 GE HealthCare Major Business
9.1.3 GE HealthCare Neuroimaging Software Product and Services
9.1.4 GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GE HealthCare Recent Developments/Updates
9.1.6 GE HealthCare Competitive Strengths & Weaknesses
9.2 Siemens Healthineers
9.2.1 Siemens Healthineers Details
9.2.2 Siemens Healthineers Major Business
9.2.3 Siemens Healthineers Neuroimaging Software Product and Services
9.2.4 Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Siemens Healthineers Recent Developments/Updates
9.2.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.3 RapidAI
9.3.1 RapidAI Details
9.3.2 RapidAI Major Business
9.3.3 RapidAI Neuroimaging Software Product and Services
9.3.4 RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 RapidAI Recent Developments/Updates
9.3.6 RapidAI Competitive Strengths & Weaknesses
9.4 Viz.ai
9.4.1 Viz.ai Details
9.4.2 Viz.ai Major Business
9.4.3 Viz.ai Neuroimaging Software Product and Services
9.4.4 Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Viz.ai Recent Developments/Updates
9.4.6 Viz.ai Competitive Strengths & Weaknesses
9.5 Philips
9.5.1 Philips Details
9.5.2 Philips Major Business
9.5.3 Philips Neuroimaging Software Product and Services
9.5.4 Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Philips Recent Developments/Updates
9.5.6 Philips Competitive Strengths & Weaknesses
9.6 Brainlab
9.6.1 Brainlab Details
9.6.2 Brainlab Major Business
9.6.3 Brainlab Neuroimaging Software Product and Services
9.6.4 Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Brainlab Recent Developments/Updates
9.6.6 Brainlab Competitive Strengths & Weaknesses
9.7 Canon
9.7.1 Canon Details
9.7.2 Canon Major Business
9.7.3 Canon Neuroimaging Software Product and Services
9.7.4 Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Canon Recent Developments/Updates
9.7.6 Canon Competitive Strengths & Weaknesses
9.8 Fujifilm
9.8.1 Fujifilm Details
9.8.2 Fujifilm Major Business
9.8.3 Fujifilm Neuroimaging Software Product and Services
9.8.4 Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Fujifilm Recent Developments/Updates
9.8.6 Fujifilm Competitive Strengths & Weaknesses
9.9 Brainomix
9.9.1 Brainomix Details
9.9.2 Brainomix Major Business
9.9.3 Brainomix Neuroimaging Software Product and Services
9.9.4 Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Brainomix Recent Developments/Updates
9.9.6 Brainomix Competitive Strengths & Weaknesses
9.10 Bruker
9.10.1 Bruker Details
9.10.2 Bruker Major Business
9.10.3 Bruker Neuroimaging Software Product and Services
9.10.4 Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Bruker Recent Developments/Updates
9.10.6 Bruker Competitive Strengths & Weaknesses
9.11 Cortechs.ai
9.11.1 Cortechs.ai Details
9.11.2 Cortechs.ai Major Business
9.11.3 Cortechs.ai Neuroimaging Software Product and Services
9.11.4 Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cortechs.ai Recent Developments/Updates
9.11.6 Cortechs.ai Competitive Strengths & Weaknesses
9.12 RadNet
9.12.1 RadNet Details
9.12.2 RadNet Major Business
9.12.3 RadNet Neuroimaging Software Product and Services
9.12.4 RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 RadNet Recent Developments/Updates
9.12.6 RadNet Competitive Strengths & Weaknesses
9.13 Aidoc
9.13.1 Aidoc Details
9.13.2 Aidoc Major Business
9.13.3 Aidoc Neuroimaging Software Product and Services
9.13.4 Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Aidoc Recent Developments/Updates
9.13.6 Aidoc Competitive Strengths & Weaknesses
9.14 ConcertAI
9.14.1 ConcertAI Details
9.14.2 ConcertAI Major Business
9.14.3 ConcertAI Neuroimaging Software Product and Services
9.14.4 ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 ConcertAI Recent Developments/Updates
9.14.6 ConcertAI Competitive Strengths & Weaknesses
9.15 Qure.ai
9.15.1 Qure.ai Details
9.15.2 Qure.ai Major Business
9.15.3 Qure.ai Neuroimaging Software Product and Services
9.15.4 Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Qure.ai Recent Developments/Updates
9.15.6 Qure.ai Competitive Strengths & Weaknesses
9.16 United Imaging Intelligence
9.16.1 United Imaging Intelligence Details
9.16.2 United Imaging Intelligence Major Business
9.16.3 United Imaging Intelligence Neuroimaging Software Product and Services
9.16.4 United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 United Imaging Intelligence Recent Developments/Updates
9.16.6 United Imaging Intelligence Competitive Strengths & Weaknesses
9.17 Shukun Technology
9.17.1 Shukun Technology Details
9.17.2 Shukun Technology Major Business
9.17.3 Shukun Technology Neuroimaging Software Product and Services
9.17.4 Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shukun Technology Recent Developments/Updates
9.17.6 Shukun Technology Competitive Strengths & Weaknesses
9.18 Infervision
9.18.1 Infervision Details
9.18.2 Infervision Major Business
9.18.3 Infervision Neuroimaging Software Product and Services
9.18.4 Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Infervision Recent Developments/Updates
9.18.6 Infervision Competitive Strengths & Weaknesses
9.19 Stryker
9.19.1 Stryker Details
9.19.2 Stryker Major Business
9.19.3 Stryker Neuroimaging Software Product and Services
9.19.4 Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Stryker Recent Developments/Updates
9.19.6 Stryker Competitive Strengths & Weaknesses
9.20 Nicolab
9.20.1 Nicolab Details
9.20.2 Nicolab Major Business
9.20.3 Nicolab Neuroimaging Software Product and Services
9.20.4 Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Nicolab Recent Developments/Updates
9.20.6 Nicolab Competitive Strengths & Weaknesses
9.21 Avicenna.AI
9.21.1 Avicenna.AI Details
9.21.2 Avicenna.AI Major Business
9.21.3 Avicenna.AI Neuroimaging Software Product and Services
9.21.4 Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Avicenna.AI Recent Developments/Updates
9.21.6 Avicenna.AI Competitive Strengths & Weaknesses
9.22 Synaptive Medical
9.22.1 Synaptive Medical Details
9.22.2 Synaptive Medical Major Business
9.22.3 Synaptive Medical Neuroimaging Software Product and Services
9.22.4 Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Synaptive Medical Recent Developments/Updates
9.22.6 Synaptive Medical Competitive Strengths & Weaknesses
9.23 Quibim
9.23.1 Quibim Details
9.23.2 Quibim Major Business
9.23.3 Quibim Neuroimaging Software Product and Services
9.23.4 Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Quibim Recent Developments/Updates
9.23.6 Quibim Competitive Strengths & Weaknesses
9.24 Surgical Theater
9.24.1 Surgical Theater Details
9.24.2 Surgical Theater Major Business
9.24.3 Surgical Theater Neuroimaging Software Product and Services
9.24.4 Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Surgical Theater Recent Developments/Updates
9.24.6 Surgical Theater Competitive Strengths & Weaknesses
9.25 mediaire
9.25.1 mediaire Details
9.25.2 mediaire Major Business
9.25.3 mediaire Neuroimaging Software Product and Services
9.25.4 mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 mediaire Recent Developments/Updates
9.25.6 mediaire Competitive Strengths & Weaknesses
9.26 Qynapse
9.26.1 Qynapse Details
9.26.2 Qynapse Major Business
9.26.3 Qynapse Neuroimaging Software Product and Services
9.26.4 Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Qynapse Recent Developments/Updates
9.26.6 Qynapse Competitive Strengths & Weaknesses
9.27 Thermo Fisher
9.27.1 Thermo Fisher Details
9.27.2 Thermo Fisher Major Business
9.27.3 Thermo Fisher Neuroimaging Software Product and Services
9.27.4 Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Thermo Fisher Recent Developments/Updates
9.27.6 Thermo Fisher Competitive Strengths & Weaknesses
9.28 Hermes Medical Solutions
9.28.1 Hermes Medical Solutions Details
9.28.2 Hermes Medical Solutions Major Business
9.28.3 Hermes Medical Solutions Neuroimaging Software Product and Services
9.28.4 Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Hermes Medical Solutions Recent Developments/Updates
9.28.6 Hermes Medical Solutions Competitive Strengths & Weaknesses
9.29 Omniscient Neurotechnology
9.29.1 Omniscient Neurotechnology Details
9.29.2 Omniscient Neurotechnology Major Business
9.29.3 Omniscient Neurotechnology Neuroimaging Software Product and Services
9.29.4 Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Omniscient Neurotechnology Recent Developments/Updates
9.29.6 Omniscient Neurotechnology Competitive Strengths & Weaknesses
9.30 IQ-AI
9.30.1 IQ-AI Details
9.30.2 IQ-AI Major Business
9.30.3 IQ-AI Neuroimaging Software Product and Services
9.30.4 IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 IQ-AI Recent Developments/Updates
9.30.6 IQ-AI Competitive Strengths & Weaknesses
9.31 Neurophet
9.31.1 Neurophet Details
9.31.2 Neurophet Major Business
9.31.3 Neurophet Neuroimaging Software Product and Services
9.31.4 Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Neurophet Recent Developments/Updates
9.31.6 Neurophet Competitive Strengths & Weaknesses
9.32 LPIXEL
9.32.1 LPIXEL Details
9.32.2 LPIXEL Major Business
9.32.3 LPIXEL Neuroimaging Software Product and Services
9.32.4 LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 LPIXEL Recent Developments/Updates
9.32.6 LPIXEL Competitive Strengths & Weaknesses
9.33 JLK
9.33.1 JLK Details
9.33.2 JLK Major Business
9.33.3 JLK Neuroimaging Software Product and Services
9.33.4 JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 JLK Recent Developments/Updates
9.33.6 JLK Competitive Strengths & Weaknesses
9.34 Brainreader
9.34.1 Brainreader Details
9.34.2 Brainreader Major Business
9.34.3 Brainreader Neuroimaging Software Product and Services
9.34.4 Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Brainreader Recent Developments/Updates
9.34.6 Brainreader Competitive Strengths & Weaknesses
9.35 NordicNeuroLab
9.35.1 NordicNeuroLab Details
9.35.2 NordicNeuroLab Major Business
9.35.3 NordicNeuroLab Neuroimaging Software Product and Services
9.35.4 NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 NordicNeuroLab Recent Developments/Updates
9.35.6 NordicNeuroLab Competitive Strengths & Weaknesses
9.36 VUNO
9.36.1 VUNO Details
9.36.2 VUNO Major Business
9.36.3 VUNO Neuroimaging Software Product and Services
9.36.4 VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 VUNO Recent Developments/Updates
9.36.6 VUNO Competitive Strengths & Weaknesses
9.37 Heuron
9.37.1 Heuron Details
9.37.2 Heuron Major Business
9.37.3 Heuron Neuroimaging Software Product and Services
9.37.4 Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 Heuron Recent Developments/Updates
9.37.6 Heuron Competitive Strengths & Weaknesses
9.38 Coreline Soft
9.38.1 Coreline Soft Details
9.38.2 Coreline Soft Major Business
9.38.3 Coreline Soft Neuroimaging Software Product and Services
9.38.4 Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Coreline Soft Recent Developments/Updates
9.38.6 Coreline Soft Competitive Strengths & Weaknesses
9.39 Cercare Medical
9.39.1 Cercare Medical Details
9.39.2 Cercare Medical Major Business
9.39.3 Cercare Medical Neuroimaging Software Product and Services
9.39.4 Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Cercare Medical Recent Developments/Updates
9.39.6 Cercare Medical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neuroimaging Software Industry Chain
10.2 Neuroimaging Software Upstream Analysis
10.3 Neuroimaging Software Midstream Analysis
10.4 Neuroimaging Software Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Neuroimaging Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neuroimaging Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neuroimaging Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neuroimaging Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neuroimaging Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuroimaging Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neuroimaging Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neuroimaging Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neuroimaging Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neuroimaging Software Players in 2025
Table 12. World Neuroimaging Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neuroimaging Software Company Evaluation Quadrant
Table 14. Head Office of Key Neuroimaging Software Players
Table 15. Neuroimaging Software Market: Company Product Type Footprint
Table 16. Neuroimaging Software Market: Company Product Application Footprint
Table 17. Neuroimaging Software Mergers & Acquisitions Activity
Table 18. United States VS China Neuroimaging Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neuroimaging Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neuroimaging Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuroimaging Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 23. China Based Neuroimaging Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuroimaging Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neuroimaging Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neuroimaging Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 29. World Neuroimaging Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neuroimaging Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neuroimaging Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neuroimaging Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 33. World Neuroimaging Software Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 34. World Neuroimaging Software Market Size by Deployment Model (2027-2032) & (USD Million)
Table 35. World Neuroimaging Software Market Size by Intended Use, (USD Million), 2021 & 2025 & 2032
Table 36. World Neuroimaging Software Market Size Value by Intended Use (2021-2026) & (USD Million)
Table 37. World Neuroimaging Software Market Size by Intended Use (2027-2032) & (USD Million)
Table 38. World Neuroimaging Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Neuroimaging Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Neuroimaging Software Market Size by Application (2027-2032) & (USD Million)
Table 41. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 42. GE HealthCare Major Business
Table 43. GE HealthCare Neuroimaging Software Product and Services
Table 44. GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GE HealthCare Recent Developments/Updates
Table 46. GE HealthCare Competitive Strengths & Weaknesses
Table 47. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 48. Siemens Healthineers Major Business
Table 49. Siemens Healthineers Neuroimaging Software Product and Services
Table 50. Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Siemens Healthineers Recent Developments/Updates
Table 52. Siemens Healthineers Competitive Strengths & Weaknesses
Table 53. RapidAI Basic Information, Manufacturing Base and Competitors
Table 54. RapidAI Major Business
Table 55. RapidAI Neuroimaging Software Product and Services
Table 56. RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. RapidAI Recent Developments/Updates
Table 58. RapidAI Competitive Strengths & Weaknesses
Table 59. Viz.ai Basic Information, Manufacturing Base and Competitors
Table 60. Viz.ai Major Business
Table 61. Viz.ai Neuroimaging Software Product and Services
Table 62. Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Viz.ai Recent Developments/Updates
Table 64. Viz.ai Competitive Strengths & Weaknesses
Table 65. Philips Basic Information, Manufacturing Base and Competitors
Table 66. Philips Major Business
Table 67. Philips Neuroimaging Software Product and Services
Table 68. Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Philips Recent Developments/Updates
Table 70. Philips Competitive Strengths & Weaknesses
Table 71. Brainlab Basic Information, Manufacturing Base and Competitors
Table 72. Brainlab Major Business
Table 73. Brainlab Neuroimaging Software Product and Services
Table 74. Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Brainlab Recent Developments/Updates
Table 76. Brainlab Competitive Strengths & Weaknesses
Table 77. Canon Basic Information, Manufacturing Base and Competitors
Table 78. Canon Major Business
Table 79. Canon Neuroimaging Software Product and Services
Table 80. Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Canon Recent Developments/Updates
Table 82. Canon Competitive Strengths & Weaknesses
Table 83. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 84. Fujifilm Major Business
Table 85. Fujifilm Neuroimaging Software Product and Services
Table 86. Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Fujifilm Recent Developments/Updates
Table 88. Fujifilm Competitive Strengths & Weaknesses
Table 89. Brainomix Basic Information, Manufacturing Base and Competitors
Table 90. Brainomix Major Business
Table 91. Brainomix Neuroimaging Software Product and Services
Table 92. Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Brainomix Recent Developments/Updates
Table 94. Brainomix Competitive Strengths & Weaknesses
Table 95. Bruker Basic Information, Manufacturing Base and Competitors
Table 96. Bruker Major Business
Table 97. Bruker Neuroimaging Software Product and Services
Table 98. Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Bruker Recent Developments/Updates
Table 100. Bruker Competitive Strengths & Weaknesses
Table 101. Cortechs.ai Basic Information, Manufacturing Base and Competitors
Table 102. Cortechs.ai Major Business
Table 103. Cortechs.ai Neuroimaging Software Product and Services
Table 104. Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cortechs.ai Recent Developments/Updates
Table 106. Cortechs.ai Competitive Strengths & Weaknesses
Table 107. RadNet Basic Information, Manufacturing Base and Competitors
Table 108. RadNet Major Business
Table 109. RadNet Neuroimaging Software Product and Services
Table 110. RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. RadNet Recent Developments/Updates
Table 112. RadNet Competitive Strengths & Weaknesses
Table 113. Aidoc Basic Information, Manufacturing Base and Competitors
Table 114. Aidoc Major Business
Table 115. Aidoc Neuroimaging Software Product and Services
Table 116. Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Aidoc Recent Developments/Updates
Table 118. Aidoc Competitive Strengths & Weaknesses
Table 119. ConcertAI Basic Information, Manufacturing Base and Competitors
Table 120. ConcertAI Major Business
Table 121. ConcertAI Neuroimaging Software Product and Services
Table 122. ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. ConcertAI Recent Developments/Updates
Table 124. ConcertAI Competitive Strengths & Weaknesses
Table 125. Qure.ai Basic Information, Manufacturing Base and Competitors
Table 126. Qure.ai Major Business
Table 127. Qure.ai Neuroimaging Software Product and Services
Table 128. Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Qure.ai Recent Developments/Updates
Table 130. Qure.ai Competitive Strengths & Weaknesses
Table 131. United Imaging Intelligence Basic Information, Manufacturing Base and Competitors
Table 132. United Imaging Intelligence Major Business
Table 133. United Imaging Intelligence Neuroimaging Software Product and Services
Table 134. United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. United Imaging Intelligence Recent Developments/Updates
Table 136. United Imaging Intelligence Competitive Strengths & Weaknesses
Table 137. Shukun Technology Basic Information, Manufacturing Base and Competitors
Table 138. Shukun Technology Major Business
Table 139. Shukun Technology Neuroimaging Software Product and Services
Table 140. Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shukun Technology Recent Developments/Updates
Table 142. Shukun Technology Competitive Strengths & Weaknesses
Table 143. Infervision Basic Information, Manufacturing Base and Competitors
Table 144. Infervision Major Business
Table 145. Infervision Neuroimaging Software Product and Services
Table 146. Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Infervision Recent Developments/Updates
Table 148. Infervision Competitive Strengths & Weaknesses
Table 149. Stryker Basic Information, Manufacturing Base and Competitors
Table 150. Stryker Major Business
Table 151. Stryker Neuroimaging Software Product and Services
Table 152. Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Stryker Recent Developments/Updates
Table 154. Stryker Competitive Strengths & Weaknesses
Table 155. Nicolab Basic Information, Manufacturing Base and Competitors
Table 156. Nicolab Major Business
Table 157. Nicolab Neuroimaging Software Product and Services
Table 158. Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Nicolab Recent Developments/Updates
Table 160. Nicolab Competitive Strengths & Weaknesses
Table 161. Avicenna.AI Basic Information, Manufacturing Base and Competitors
Table 162. Avicenna.AI Major Business
Table 163. Avicenna.AI Neuroimaging Software Product and Services
Table 164. Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Avicenna.AI Recent Developments/Updates
Table 166. Avicenna.AI Competitive Strengths & Weaknesses
Table 167. Synaptive Medical Basic Information, Manufacturing Base and Competitors
Table 168. Synaptive Medical Major Business
Table 169. Synaptive Medical Neuroimaging Software Product and Services
Table 170. Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Synaptive Medical Recent Developments/Updates
Table 172. Synaptive Medical Competitive Strengths & Weaknesses
Table 173. Quibim Basic Information, Manufacturing Base and Competitors
Table 174. Quibim Major Business
Table 175. Quibim Neuroimaging Software Product and Services
Table 176. Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Quibim Recent Developments/Updates
Table 178. Quibim Competitive Strengths & Weaknesses
Table 179. Surgical Theater Basic Information, Manufacturing Base and Competitors
Table 180. Surgical Theater Major Business
Table 181. Surgical Theater Neuroimaging Software Product and Services
Table 182. Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Surgical Theater Recent Developments/Updates
Table 184. Surgical Theater Competitive Strengths & Weaknesses
Table 185. mediaire Basic Information, Manufacturing Base and Competitors
Table 186. mediaire Major Business
Table 187. mediaire Neuroimaging Software Product and Services
Table 188. mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. mediaire Recent Developments/Updates
Table 190. mediaire Competitive Strengths & Weaknesses
Table 191. Qynapse Basic Information, Manufacturing Base and Competitors
Table 192. Qynapse Major Business
Table 193. Qynapse Neuroimaging Software Product and Services
Table 194. Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Qynapse Recent Developments/Updates
Table 196. Qynapse Competitive Strengths & Weaknesses
Table 197. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 198. Thermo Fisher Major Business
Table 199. Thermo Fisher Neuroimaging Software Product and Services
Table 200. Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Thermo Fisher Recent Developments/Updates
Table 202. Thermo Fisher Competitive Strengths & Weaknesses
Table 203. Hermes Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 204. Hermes Medical Solutions Major Business
Table 205. Hermes Medical Solutions Neuroimaging Software Product and Services
Table 206. Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Hermes Medical Solutions Recent Developments/Updates
Table 208. Hermes Medical Solutions Competitive Strengths & Weaknesses
Table 209. Omniscient Neurotechnology Basic Information, Manufacturing Base and Competitors
Table 210. Omniscient Neurotechnology Major Business
Table 211. Omniscient Neurotechnology Neuroimaging Software Product and Services
Table 212. Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Omniscient Neurotechnology Recent Developments/Updates
Table 214. Omniscient Neurotechnology Competitive Strengths & Weaknesses
Table 215. IQ-AI Basic Information, Manufacturing Base and Competitors
Table 216. IQ-AI Major Business
Table 217. IQ-AI Neuroimaging Software Product and Services
Table 218. IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. IQ-AI Recent Developments/Updates
Table 220. IQ-AI Competitive Strengths & Weaknesses
Table 221. Neurophet Basic Information, Manufacturing Base and Competitors
Table 222. Neurophet Major Business
Table 223. Neurophet Neuroimaging Software Product and Services
Table 224. Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Neurophet Recent Developments/Updates
Table 226. Neurophet Competitive Strengths & Weaknesses
Table 227. LPIXEL Basic Information, Manufacturing Base and Competitors
Table 228. LPIXEL Major Business
Table 229. LPIXEL Neuroimaging Software Product and Services
Table 230. LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. LPIXEL Recent Developments/Updates
Table 232. LPIXEL Competitive Strengths & Weaknesses
Table 233. JLK Basic Information, Manufacturing Base and Competitors
Table 234. JLK Major Business
Table 235. JLK Neuroimaging Software Product and Services
Table 236. JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. JLK Recent Developments/Updates
Table 238. JLK Competitive Strengths & Weaknesses
Table 239. Brainreader Basic Information, Manufacturing Base and Competitors
Table 240. Brainreader Major Business
Table 241. Brainreader Neuroimaging Software Product and Services
Table 242. Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Brainreader Recent Developments/Updates
Table 244. Brainreader Competitive Strengths & Weaknesses
Table 245. NordicNeuroLab Basic Information, Manufacturing Base and Competitors
Table 246. NordicNeuroLab Major Business
Table 247. NordicNeuroLab Neuroimaging Software Product and Services
Table 248. NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. NordicNeuroLab Recent Developments/Updates
Table 250. NordicNeuroLab Competitive Strengths & Weaknesses
Table 251. VUNO Basic Information, Manufacturing Base and Competitors
Table 252. VUNO Major Business
Table 253. VUNO Neuroimaging Software Product and Services
Table 254. VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. VUNO Recent Developments/Updates
Table 256. VUNO Competitive Strengths & Weaknesses
Table 257. Heuron Basic Information, Manufacturing Base and Competitors
Table 258. Heuron Major Business
Table 259. Heuron Neuroimaging Software Product and Services
Table 260. Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. Heuron Recent Developments/Updates
Table 262. Heuron Competitive Strengths & Weaknesses
Table 263. Coreline Soft Basic Information, Manufacturing Base and Competitors
Table 264. Coreline Soft Major Business
Table 265. Coreline Soft Neuroimaging Software Product and Services
Table 266. Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Coreline Soft Recent Developments/Updates
Table 268. Coreline Soft Competitive Strengths & Weaknesses
Table 269. Cercare Medical Basic Information, Manufacturing Base and Competitors
Table 270. Cercare Medical Major Business
Table 271. Cercare Medical Neuroimaging Software Product and Services
Table 272. Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Cercare Medical Recent Developments/Updates
Table 274. Cercare Medical Competitive Strengths & Weaknesses
Table 275. Global Key Players of Neuroimaging Software Upstream (Raw Materials)
Table 276. Global Neuroimaging Software Typical Customers
Table 1. World Neuroimaging Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neuroimaging Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neuroimaging Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neuroimaging Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neuroimaging Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neuroimaging Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neuroimaging Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neuroimaging Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neuroimaging Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neuroimaging Software Players in 2025
Table 12. World Neuroimaging Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neuroimaging Software Company Evaluation Quadrant
Table 14. Head Office of Key Neuroimaging Software Players
Table 15. Neuroimaging Software Market: Company Product Type Footprint
Table 16. Neuroimaging Software Market: Company Product Application Footprint
Table 17. Neuroimaging Software Mergers & Acquisitions Activity
Table 18. United States VS China Neuroimaging Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neuroimaging Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neuroimaging Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neuroimaging Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 23. China Based Neuroimaging Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neuroimaging Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neuroimaging Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neuroimaging Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neuroimaging Software Revenue Market Share (2021-2026)
Table 29. World Neuroimaging Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neuroimaging Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neuroimaging Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neuroimaging Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 33. World Neuroimaging Software Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 34. World Neuroimaging Software Market Size by Deployment Model (2027-2032) & (USD Million)
Table 35. World Neuroimaging Software Market Size by Intended Use, (USD Million), 2021 & 2025 & 2032
Table 36. World Neuroimaging Software Market Size Value by Intended Use (2021-2026) & (USD Million)
Table 37. World Neuroimaging Software Market Size by Intended Use (2027-2032) & (USD Million)
Table 38. World Neuroimaging Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Neuroimaging Software Market Size by Application (2021-2026) & (USD Million)
Table 40. World Neuroimaging Software Market Size by Application (2027-2032) & (USD Million)
Table 41. GE HealthCare Basic Information, Manufacturing Base and Competitors
Table 42. GE HealthCare Major Business
Table 43. GE HealthCare Neuroimaging Software Product and Services
Table 44. GE HealthCare Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GE HealthCare Recent Developments/Updates
Table 46. GE HealthCare Competitive Strengths & Weaknesses
Table 47. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 48. Siemens Healthineers Major Business
Table 49. Siemens Healthineers Neuroimaging Software Product and Services
Table 50. Siemens Healthineers Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Siemens Healthineers Recent Developments/Updates
Table 52. Siemens Healthineers Competitive Strengths & Weaknesses
Table 53. RapidAI Basic Information, Manufacturing Base and Competitors
Table 54. RapidAI Major Business
Table 55. RapidAI Neuroimaging Software Product and Services
Table 56. RapidAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. RapidAI Recent Developments/Updates
Table 58. RapidAI Competitive Strengths & Weaknesses
Table 59. Viz.ai Basic Information, Manufacturing Base and Competitors
Table 60. Viz.ai Major Business
Table 61. Viz.ai Neuroimaging Software Product and Services
Table 62. Viz.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Viz.ai Recent Developments/Updates
Table 64. Viz.ai Competitive Strengths & Weaknesses
Table 65. Philips Basic Information, Manufacturing Base and Competitors
Table 66. Philips Major Business
Table 67. Philips Neuroimaging Software Product and Services
Table 68. Philips Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Philips Recent Developments/Updates
Table 70. Philips Competitive Strengths & Weaknesses
Table 71. Brainlab Basic Information, Manufacturing Base and Competitors
Table 72. Brainlab Major Business
Table 73. Brainlab Neuroimaging Software Product and Services
Table 74. Brainlab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Brainlab Recent Developments/Updates
Table 76. Brainlab Competitive Strengths & Weaknesses
Table 77. Canon Basic Information, Manufacturing Base and Competitors
Table 78. Canon Major Business
Table 79. Canon Neuroimaging Software Product and Services
Table 80. Canon Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Canon Recent Developments/Updates
Table 82. Canon Competitive Strengths & Weaknesses
Table 83. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 84. Fujifilm Major Business
Table 85. Fujifilm Neuroimaging Software Product and Services
Table 86. Fujifilm Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Fujifilm Recent Developments/Updates
Table 88. Fujifilm Competitive Strengths & Weaknesses
Table 89. Brainomix Basic Information, Manufacturing Base and Competitors
Table 90. Brainomix Major Business
Table 91. Brainomix Neuroimaging Software Product and Services
Table 92. Brainomix Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Brainomix Recent Developments/Updates
Table 94. Brainomix Competitive Strengths & Weaknesses
Table 95. Bruker Basic Information, Manufacturing Base and Competitors
Table 96. Bruker Major Business
Table 97. Bruker Neuroimaging Software Product and Services
Table 98. Bruker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Bruker Recent Developments/Updates
Table 100. Bruker Competitive Strengths & Weaknesses
Table 101. Cortechs.ai Basic Information, Manufacturing Base and Competitors
Table 102. Cortechs.ai Major Business
Table 103. Cortechs.ai Neuroimaging Software Product and Services
Table 104. Cortechs.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cortechs.ai Recent Developments/Updates
Table 106. Cortechs.ai Competitive Strengths & Weaknesses
Table 107. RadNet Basic Information, Manufacturing Base and Competitors
Table 108. RadNet Major Business
Table 109. RadNet Neuroimaging Software Product and Services
Table 110. RadNet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. RadNet Recent Developments/Updates
Table 112. RadNet Competitive Strengths & Weaknesses
Table 113. Aidoc Basic Information, Manufacturing Base and Competitors
Table 114. Aidoc Major Business
Table 115. Aidoc Neuroimaging Software Product and Services
Table 116. Aidoc Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Aidoc Recent Developments/Updates
Table 118. Aidoc Competitive Strengths & Weaknesses
Table 119. ConcertAI Basic Information, Manufacturing Base and Competitors
Table 120. ConcertAI Major Business
Table 121. ConcertAI Neuroimaging Software Product and Services
Table 122. ConcertAI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. ConcertAI Recent Developments/Updates
Table 124. ConcertAI Competitive Strengths & Weaknesses
Table 125. Qure.ai Basic Information, Manufacturing Base and Competitors
Table 126. Qure.ai Major Business
Table 127. Qure.ai Neuroimaging Software Product and Services
Table 128. Qure.ai Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Qure.ai Recent Developments/Updates
Table 130. Qure.ai Competitive Strengths & Weaknesses
Table 131. United Imaging Intelligence Basic Information, Manufacturing Base and Competitors
Table 132. United Imaging Intelligence Major Business
Table 133. United Imaging Intelligence Neuroimaging Software Product and Services
Table 134. United Imaging Intelligence Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. United Imaging Intelligence Recent Developments/Updates
Table 136. United Imaging Intelligence Competitive Strengths & Weaknesses
Table 137. Shukun Technology Basic Information, Manufacturing Base and Competitors
Table 138. Shukun Technology Major Business
Table 139. Shukun Technology Neuroimaging Software Product and Services
Table 140. Shukun Technology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shukun Technology Recent Developments/Updates
Table 142. Shukun Technology Competitive Strengths & Weaknesses
Table 143. Infervision Basic Information, Manufacturing Base and Competitors
Table 144. Infervision Major Business
Table 145. Infervision Neuroimaging Software Product and Services
Table 146. Infervision Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Infervision Recent Developments/Updates
Table 148. Infervision Competitive Strengths & Weaknesses
Table 149. Stryker Basic Information, Manufacturing Base and Competitors
Table 150. Stryker Major Business
Table 151. Stryker Neuroimaging Software Product and Services
Table 152. Stryker Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Stryker Recent Developments/Updates
Table 154. Stryker Competitive Strengths & Weaknesses
Table 155. Nicolab Basic Information, Manufacturing Base and Competitors
Table 156. Nicolab Major Business
Table 157. Nicolab Neuroimaging Software Product and Services
Table 158. Nicolab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Nicolab Recent Developments/Updates
Table 160. Nicolab Competitive Strengths & Weaknesses
Table 161. Avicenna.AI Basic Information, Manufacturing Base and Competitors
Table 162. Avicenna.AI Major Business
Table 163. Avicenna.AI Neuroimaging Software Product and Services
Table 164. Avicenna.AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Avicenna.AI Recent Developments/Updates
Table 166. Avicenna.AI Competitive Strengths & Weaknesses
Table 167. Synaptive Medical Basic Information, Manufacturing Base and Competitors
Table 168. Synaptive Medical Major Business
Table 169. Synaptive Medical Neuroimaging Software Product and Services
Table 170. Synaptive Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Synaptive Medical Recent Developments/Updates
Table 172. Synaptive Medical Competitive Strengths & Weaknesses
Table 173. Quibim Basic Information, Manufacturing Base and Competitors
Table 174. Quibim Major Business
Table 175. Quibim Neuroimaging Software Product and Services
Table 176. Quibim Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Quibim Recent Developments/Updates
Table 178. Quibim Competitive Strengths & Weaknesses
Table 179. Surgical Theater Basic Information, Manufacturing Base and Competitors
Table 180. Surgical Theater Major Business
Table 181. Surgical Theater Neuroimaging Software Product and Services
Table 182. Surgical Theater Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Surgical Theater Recent Developments/Updates
Table 184. Surgical Theater Competitive Strengths & Weaknesses
Table 185. mediaire Basic Information, Manufacturing Base and Competitors
Table 186. mediaire Major Business
Table 187. mediaire Neuroimaging Software Product and Services
Table 188. mediaire Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. mediaire Recent Developments/Updates
Table 190. mediaire Competitive Strengths & Weaknesses
Table 191. Qynapse Basic Information, Manufacturing Base and Competitors
Table 192. Qynapse Major Business
Table 193. Qynapse Neuroimaging Software Product and Services
Table 194. Qynapse Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Qynapse Recent Developments/Updates
Table 196. Qynapse Competitive Strengths & Weaknesses
Table 197. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 198. Thermo Fisher Major Business
Table 199. Thermo Fisher Neuroimaging Software Product and Services
Table 200. Thermo Fisher Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Thermo Fisher Recent Developments/Updates
Table 202. Thermo Fisher Competitive Strengths & Weaknesses
Table 203. Hermes Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 204. Hermes Medical Solutions Major Business
Table 205. Hermes Medical Solutions Neuroimaging Software Product and Services
Table 206. Hermes Medical Solutions Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Hermes Medical Solutions Recent Developments/Updates
Table 208. Hermes Medical Solutions Competitive Strengths & Weaknesses
Table 209. Omniscient Neurotechnology Basic Information, Manufacturing Base and Competitors
Table 210. Omniscient Neurotechnology Major Business
Table 211. Omniscient Neurotechnology Neuroimaging Software Product and Services
Table 212. Omniscient Neurotechnology Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Omniscient Neurotechnology Recent Developments/Updates
Table 214. Omniscient Neurotechnology Competitive Strengths & Weaknesses
Table 215. IQ-AI Basic Information, Manufacturing Base and Competitors
Table 216. IQ-AI Major Business
Table 217. IQ-AI Neuroimaging Software Product and Services
Table 218. IQ-AI Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. IQ-AI Recent Developments/Updates
Table 220. IQ-AI Competitive Strengths & Weaknesses
Table 221. Neurophet Basic Information, Manufacturing Base and Competitors
Table 222. Neurophet Major Business
Table 223. Neurophet Neuroimaging Software Product and Services
Table 224. Neurophet Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Neurophet Recent Developments/Updates
Table 226. Neurophet Competitive Strengths & Weaknesses
Table 227. LPIXEL Basic Information, Manufacturing Base and Competitors
Table 228. LPIXEL Major Business
Table 229. LPIXEL Neuroimaging Software Product and Services
Table 230. LPIXEL Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. LPIXEL Recent Developments/Updates
Table 232. LPIXEL Competitive Strengths & Weaknesses
Table 233. JLK Basic Information, Manufacturing Base and Competitors
Table 234. JLK Major Business
Table 235. JLK Neuroimaging Software Product and Services
Table 236. JLK Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. JLK Recent Developments/Updates
Table 238. JLK Competitive Strengths & Weaknesses
Table 239. Brainreader Basic Information, Manufacturing Base and Competitors
Table 240. Brainreader Major Business
Table 241. Brainreader Neuroimaging Software Product and Services
Table 242. Brainreader Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Brainreader Recent Developments/Updates
Table 244. Brainreader Competitive Strengths & Weaknesses
Table 245. NordicNeuroLab Basic Information, Manufacturing Base and Competitors
Table 246. NordicNeuroLab Major Business
Table 247. NordicNeuroLab Neuroimaging Software Product and Services
Table 248. NordicNeuroLab Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. NordicNeuroLab Recent Developments/Updates
Table 250. NordicNeuroLab Competitive Strengths & Weaknesses
Table 251. VUNO Basic Information, Manufacturing Base and Competitors
Table 252. VUNO Major Business
Table 253. VUNO Neuroimaging Software Product and Services
Table 254. VUNO Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. VUNO Recent Developments/Updates
Table 256. VUNO Competitive Strengths & Weaknesses
Table 257. Heuron Basic Information, Manufacturing Base and Competitors
Table 258. Heuron Major Business
Table 259. Heuron Neuroimaging Software Product and Services
Table 260. Heuron Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. Heuron Recent Developments/Updates
Table 262. Heuron Competitive Strengths & Weaknesses
Table 263. Coreline Soft Basic Information, Manufacturing Base and Competitors
Table 264. Coreline Soft Major Business
Table 265. Coreline Soft Neuroimaging Software Product and Services
Table 266. Coreline Soft Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Coreline Soft Recent Developments/Updates
Table 268. Coreline Soft Competitive Strengths & Weaknesses
Table 269. Cercare Medical Basic Information, Manufacturing Base and Competitors
Table 270. Cercare Medical Major Business
Table 271. Cercare Medical Neuroimaging Software Product and Services
Table 272. Cercare Medical Neuroimaging Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Cercare Medical Recent Developments/Updates
Table 274. Cercare Medical Competitive Strengths & Weaknesses
Table 275. Global Key Players of Neuroimaging Software Upstream (Raw Materials)
Table 276. Global Neuroimaging Software Typical Customers
LIST OF FIGURES
Figure 1. Neuroimaging Software Picture
Figure 2. World Neuroimaging Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neuroimaging Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neuroimaging Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neuroimaging Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 13. Neuroimaging Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neuroimaging Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neuroimaging Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuroimaging Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuroimaging Software Markets in 2025
Figure 27. United States VS China: Neuroimaging Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neuroimaging Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neuroimaging Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neuroimaging Software Market Size Market Share by Type in 2025
Figure 31. Advanced Post-processing and Visualization
Figure 32. Quantitative Biomarkers and Volumetry
Figure 33. AI Detection
Figure 34. Molecular Neuroimaging Quantification
Figure 35. Others
Figure 36. World Neuroimaging Software Market Size Market Share by Type (2021-2032)
Figure 37. World Neuroimaging Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 38. World Neuroimaging Software Market Size Market Share by Deployment Model in 2025
Figure 39. On-premise
Figure 40. Cloud-based
Figure 41. Hybrid
Figure 42. World Neuroimaging Software Market Size Market Share by Deployment Model (2021-2032)
Figure 43. World Neuroimaging Software Market Size by Intended Use, (USD Million), 2021 & 2025 & 2032
Figure 44. World Neuroimaging Software Market Size Market Share by Intended Use in 2025
Figure 45. Clinical Diagnostic or Decision Support
Figure 46. Clinical Trial or Drug Development
Figure 47. Research Use Only
Figure 48. Others
Figure 49. World Neuroimaging Software Market Size Market Share by Intended Use (2021-2032)
Figure 50. World Neuroimaging Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Neuroimaging Software Market Size Market Share by Application in 2025
Figure 52. Stroke and Cerebrovascular Disease
Figure 53. Neurodegenerative Disease and Multiple Sclerosis
Figure 54. Neuro-oncology
Figure 55. Others
Figure 56. World Neuroimaging Software Market Size Market Share by Application (2021-2032)
Figure 57. Neuroimaging Software Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Neuroimaging Software Picture
Figure 2. World Neuroimaging Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neuroimaging Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neuroimaging Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neuroimaging Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neuroimaging Software Revenue (2021-2032) & (USD Million)
Figure 13. Neuroimaging Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neuroimaging Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neuroimaging Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neuroimaging Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neuroimaging Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neuroimaging Software Markets in 2025
Figure 27. United States VS China: Neuroimaging Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neuroimaging Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neuroimaging Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neuroimaging Software Market Size Market Share by Type in 2025
Figure 31. Advanced Post-processing and Visualization
Figure 32. Quantitative Biomarkers and Volumetry
Figure 33. AI Detection
Figure 34. Molecular Neuroimaging Quantification
Figure 35. Others
Figure 36. World Neuroimaging Software Market Size Market Share by Type (2021-2032)
Figure 37. World Neuroimaging Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 38. World Neuroimaging Software Market Size Market Share by Deployment Model in 2025
Figure 39. On-premise
Figure 40. Cloud-based
Figure 41. Hybrid
Figure 42. World Neuroimaging Software Market Size Market Share by Deployment Model (2021-2032)
Figure 43. World Neuroimaging Software Market Size by Intended Use, (USD Million), 2021 & 2025 & 2032
Figure 44. World Neuroimaging Software Market Size Market Share by Intended Use in 2025
Figure 45. Clinical Diagnostic or Decision Support
Figure 46. Clinical Trial or Drug Development
Figure 47. Research Use Only
Figure 48. Others
Figure 49. World Neuroimaging Software Market Size Market Share by Intended Use (2021-2032)
Figure 50. World Neuroimaging Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Neuroimaging Software Market Size Market Share by Application in 2025
Figure 52. Stroke and Cerebrovascular Disease
Figure 53. Neurodegenerative Disease and Multiple Sclerosis
Figure 54. Neuro-oncology
Figure 55. Others
Figure 56. World Neuroimaging Software Market Size Market Share by Application (2021-2032)
Figure 57. Neuroimaging Software Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
